CaseVuCategory Archives: Press Releases
Precipio Announces Q2-2026 Financial Results
Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens cash position [...]
Aug
Precipio Announces Q2-2026 Shareholder Update Call
Conference Call will be held on August 17th, 2026, at 5:00 PM EST NEW HAVEN, [...]
Jul
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
NEW HAVEN, CT, (June 12th, 2026) – Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting [...]
Jun
Precipio to Present at the Planet MicroCap Las Vegas
NEW HAVEN, CT, Globenewswire – (June 11, 2026) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: [...]
Jun
Precipio Announces Q1 2026 Financial Results
Stable revenue performance driven by timing dynamics; expanding product pipeline expected to drive second-half growth [...]
May
Management team’s 2025 market-based Options have vested
Share price increase from $6 to $30 triggers full vesting NEW HAVEN, CT, (May 13th, [...]
May
Precipio Announces Q1-2026 Shareholder Update Call
Conference Call will be held on May 18th, 2026, at 5:00 PM EST NEW HAVEN, [...]
May
Precipio Announces Q4 and year-end 2025 Shareholder Update Call
Conference Call to be held on April 2nd, 2026 at 5:00 PM EST NEW HAVEN, [...]
Mar
Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay
This is the only assay available on the market that delivers full quantification of all [...]
Mar
Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year
In Q4-2025 the Company generated ~$400K in Operating Cash Flow, and Adjusted EBITDA of close [...]
Feb